Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


Read more


MC Services successfully attended a variety of conferences in the first months of 2017


With participation in a number of conferences all over Europe, MC Services made a successful start into 2017. For a list of attended conferences and some impressions visit us on Facebook.


Read more


MC Services sponsors Best Technology Award at the 2017 European Mediscience Awards


MC Services is proud to contribute to this year’s European Mediscience Awards as a sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.


Mediscience Awards 2017: winners announced

After months of anticipation, the voting has taken place, the shortlist has been announced, and in Thursday’s awards ceremony, this year’s winners were crowned at the European Mediscience Awards prestigious dinner, which was held at The Brewery, in London.

With representatives of private and publicly listed life sciences companies from across Europe, the awards celebration remained true to its reputation of being a must-attend networking event for industry executives.


Now that it is over, there is only one thing left to do: we warmly congratulate the winners and those who were shortlisted on their success at the European Mediscience Awards 2017. MC Services was an event sponsor for the first time this year and was very excited to have the opportunity to sponsor the 2017 Best Technology Award.


Click here for the full list of winners

Result of General Meeting and Total Voting Rights


Motif Bio Invited to Present at Infectious Diseases Conference


InflaRx Promotes Othmar Zenker, M.D. to Newly Created Position of Chief Medical Officer


MagForce AG hosts live demonstration of NanoTherm® Therapy at Long Night of the Sciences 2017 in Berlin on June 24, 2017


PeproStat Phase IIb study passes recruitment mid-point ahead of schedule


Pharnext to showcase PLEOTHERAPY™ platform at Drug Repositioning, Repurposing and Rescue Conference


Creathor Venture and private investors invest CHF 2.5 million in PropTech company Allthings


Medigene announces participation at further national and international conferences


WILEX AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates


TxCell appoints Lentigen Technology, Inc. to manufacture the lentiviral vector for its first CAR-Treg program in transplant rejection


Bencard Allergie GmbH: Allergy Therapeutics veranstaltet Satelliten-Symposium auf dem EAACI 2017


Ergomed strengthens executive team with appointment of Dr Dan Weng as CEO